GlassScriptPhysician profile
Jeffrey B Manley
NPI 1700016961
$719.76
in general payments reported to CMS, 2019-2025
15 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $33.60 · 2021: $327 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $351.76 | 2019-2025 | |
| Therapeuticsmd, INC. | $54.38 | 2019-2020 | |
| Daiichi Sankyo INC. | $52.60 | 2019 | |
| Organon LLC | $49.12 | 2021-2025 | Jada System |
| Merck Sharp & Dohme LLC | $38.80 | 2019-2021 | |
| Exeltis, USA INC. | $32.90 | 2021 | |
| Haemonetics Corporation | $22.82 | 2019 | |
| Baxter Healthcare | $22.07 | 2021 | |
| Agile Therapeutics, INC. | $19.59 | 2021 | |
| Mylan Pharmaceuticals INC. | $13.93 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.17 | 2019 | |
| Allergan, INC. | $13.09 | 2019 | |
| Pfizer INC. | $12.94 | 2019 | |
| Ethicon US, LLC | $11.59 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Manley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.